FDA recall D-0263-2022

Aurobindo Pharma USA Inc. · Class III · drug

Product

Carvedilol Tablets, USP, 6.25 mg, 500 Tablets bottle, Rx Only, Distributed by: Aurobindo Pharma USA Inc., 279 Princeton-Hightstown Road, East Windsor, NJ, 08520, Made in India, NDC 65862-143-05

Reason for recall

Failed Impurities/Degradation Specifications

Distribution

Nationwide in the US

Key facts

Status
Terminated
Initiation date
2021-11-15
Report date
2021-12-01
Termination date
2023-08-23
Voluntary/Mandated
Voluntary: Firm initiated
Location
East Windsor, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0263-2022